The aim of this study was to evaluate the feasibility and outcomes of anti-TNF-α discontinuation in children with non-systemic JIA who achieved long-term clinical remission and to explore potential predictors to inform individualized withdrawal strategies. This evidence concerns the gene TNF and juvenile idiopathic arthritis.